Je. Biaglow et al., THE MEASUREMENT OF BIOREDUCTIVE CAPACITY OF TUMOR-CELLS USING METHYLENE-BLUE, International journal of radiation oncology, biology, physics, 42(4), 1998, pp. 769-773
Citations number
16
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: Methylene blue (MB) can be used as an intracellular electron
acceptor. The purpose of this study was to demonstrate the usefulness
of MB for the determination of total bioreductive capacity of cell sus
pensions. Methods and Materials: We measured oxygen consumption by Cla
rk electrode and pentose cycle activity by release of (CO2)-C-14 from
1-C-14-glucose. Results: Methylene blue catalyzes the reaction of intr
acellular reductants NADPH, NADH, and reduced glutathione (GSH) with o
xygen, causing the production of hydrogen peroxide. The reaction rate
correlates with the negative charge of molecule (NADPH(-4) > NADH(-2)
> GSH(-1)), suggesting that reaction with positively charged oxidized
MB is the limiting step of the reaction. In a cellular system MB cause
s the electron flow from cellular endogenous substrates to oxygen. It
is activated by the disruption of the NADP(+)/NADPH ratio due to sever
al processes. These are direct oxidation of NADPH and GSH, the GSH per
oxidase catalyzed reaction of GSH with H2O2, followed by NADPH oxidati
on by oxidized glutathione (GSSG). This results in increased cellular
oxygen consumption and stimulation of the oxidative limb of pentose cy
cle (PC) in the presence of MB. The cellular effect of MB differs from
other electron accepting drugs. Diamide and tert-butylhydroperoxide a
ct as direct oxidants, while MB is an electron carrier to oxygen. Acco
rdingly, MB shows the highest effect on PC activation and oxygen consu
mption. Conclusions: Our results indicate that MB may be used for the
determination of the total bioreductive capacity of the cells, measure
d by oxygen consumption and PC activation. (C) 1998 Elsevier Science I
nc.